Please assess the completion status of the following clinical trial:

Trial Title: Artesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax Malaria

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* microscopy confirmed P. vivax mono-infection~* age \>2 years~* weight \>5kg~* \>1 asexual parasite per 10 fields~Exclusion Criteria:~* pregnant~* evidence of concomitant infection or serious disease~* recent use of antimalarial drugs~* severe malaria~* known allergy to study drugs

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).